Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:235-241

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayakawa, H.
Right arrow Articles by Raij, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayakawa, H.
Right arrow Articles by Raij, L.

(Hypertension. 1997;29:235.)
© 1997 American Heart Association, Inc.


Arthur C. Corcoran Memorial Lecture

The Link Among Nitric Oxide Synthase Activity, Endothelial Function, and Aortic and Ventricular Hypertrophy in Hypertension

Hiroshi Hayakawa; Leopoldo Raij

From the Department of Medicine, Veterans Affairs Medical Center and University of Minnesota Medical School, Minneapolis, Minn.

Correspondence to Leopoldo Raij, MD, VA Medical Center, Nephrology/Hypertension Section, III j, 1 Veterans Dr, Minneapolis, MN 55417. E-mail raijx001{at}maroon.tc.umn.edu

The adaptive changes that occur in the left ventricle (LV) and vessels in response to hypertension, namely, muscle hypertrophy/hyperplasia, endothelial dysfunction, and extracellular matrix increase, do not depend solely on blood pressure elevation. These changes are, in fact, maladaptive since they are forerunners of cardiac failure, stroke, and renal failure. Nitric oxide, an endogenous vasodilator and inhibitor of vascular smooth muscle cell growth, is synthesized in the endothelium by constitutive nitric oxide synthase (cNOS). We investigated the relationships among LV and aortic cNOS activity (conversion of [14C] L-arginine to [14C] L-citrulline), with LV hypertrophy (LV weight/body weight), and (2) aortic hypertrophy (aortic weight/ length) in spontaneously hypertensive rats (SHR) and Dahl salt-sensitive (DS) rats matched for blood pressure (219±12 versus 211±7 mm Hg, P=NS) and age. Compared with their normotensive counterparts, aortic cNOS activity was increased 106% in SHR but reduced by 73% in DS rats. The correlation between blood pressure and aortic cNOS activity was positive (r=.74, P<.01) in SHR and negative (r=-.82, P<.01) in DS rats. LV cNOS activity was increased 73% in SHR compared with normotensive Wistar-Kyoto rats (P<.01). On the other hand, LV cNOS activity was not increased in hypertensive DS rats compared with normotensive DS rats. In SHR, aortic hypertrophy did not increase significantly and LV hypertrophy increased only 15%, whereas in hypertensive DS rats the aorta and LV hyper-trophied 36% and 88%, respectively (both P<.01). Moreover, in DS rats there was a negative correlation between cNOS activity and aortic hypertrophy (r=-.70, P<.01). In DS rats, antihyper-tensive therapy consisting of an angiotensin-converting enzyme inhibitor, perindopril, and a diuretic, indapamide, normalized blood pressure, aortic cNOS activity, and LV hypertrophy and reduced aortic hypertrophy. Our studies imply that upregulation of vascular cNOS activity has a protective cardiovascular homeostatic role in hypertension. Clinically, the variable end-organ disease observed in individuals with similar severity of hypertension may be explained, at least in part, by genetically conditioned differences in vascular cNOS activity in response to hypertension.


Key Words: endothelium • nitric oxide synthase • rats, inbred, SHR • rats, Dahl • muscle, smooth, vascular • hypertrophy, left ventricular • hypertension

Abbreviations: ACE = angiotensin-converting enzyme • Ach = acetylcholine • cNOS = constitutive NO synthase • DR = Dahl salt-resistant • DR-0.5% = DR rats receiving 0.5% salt diet • DR-4.0% = DR rats receiving 4.0% salt diet • DS = Dahl salt-sensitive • DS-4.0% = DS rats receiving 4.0% salt • DS-0.5% = DS rats receiving 0.5% salt • DS-Rx = DS rats fed 4.0% NaCl diet + antihypertensive therapy with perindopril and indapamide • EDRelax = endothelium-dependent relaxation • iNOS = inducible NO synthase • LV = left ventricular • NO = nitric oxide • NOS = nitric oxide synthase • NOx = NO2/NO3 • SBP = systolic blood pressure • SHR = spontaneously hypertensive rat • SNP = sodium nitroprusside • WKY = Wistar-Kyoto




This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
O. Gokalp, S. Ozdem, S. Donmez, M. Dogan, H. Demirin, Y. Kara, R. Sutcu, E. Cicek, M. Ozer, and N. Delibas
Impairment of endothelium-dependent vasorelaxation in cadmium-hypertensive rats
Toxicology and Industrial Health, August 1, 2009; 25(7): 447 - 453.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
R. Zhang, Y.-G. Bai, L.-J. Lin, J.-X. Bao, Y.-Y. Zhang, H. Tang, J.-H. Cheng, G.-L. Jia, X.-L. Ren, and J. Ma
Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats
J Appl Physiol, January 1, 2009; 106(1): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. H. Schulman, M.-S. Zhou, E. A. Jaimes, and L. Raij
Dissociation between metabolic and vascular insulin resistance in aging
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H853 - H859.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. W. E. Rush, J. Quadrilatero, A. S. Levy, and R. J. Ford
Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats
Experimental Biology and Medicine, June 1, 2007; 232(6): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Yamamoto, T. Yamashita, T. Tanaka, K. Kataoka, Y. Tokutomi, Z.-F. Lai, Y.-F. Dong, S. Matsuba, H. Ogawa, and S. Kim-Mitsuyama
Pravastatin Enhances Beneficial Effects of Olmesartan on Vascular Injury of Salt-Sensitive Hypertensive Rats, via Pleiotropic Effects
Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 556 - 563.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Banday, A. B. Muhammad, F. R. Fazili, and M. Lokhandwala
Mechanisms of Oxidative Stress-Induced Increase in Salt Sensitivity and Development of Hypertension in Sprague-Dawley Rats
Hypertension, March 1, 2007; 49(3): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-S. Zhou, I. H. Schulman, P. J. Pagano, E. A. Jaimes, and L. Raij
Reduced NAD(P)H Oxidase in Low Renin Hypertension: Link Among Angiotensin II, Atherogenesis, and Blood Pressure
Hypertension, January 1, 2006; 47(1): 81 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. K. Johnson, R. A. Johnson, K. J. Peyton, and W. Durante
Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1057 - R1062.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. J. Teran, R. A. Johnson, B. K. Stevenson, K. J. Peyton, K. E. Jackson, S. D. Appleton, W. Durante, and F. K. Johnson
Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R615 - R622.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-S. Zhou, E. A. Jaimes, and L. Raij
Atorvastatin Prevents End-Organ Injury in Salt-Sensitive Hypertension: Role of eNOS and Oxidant Stress
Hypertension, August 1, 2004; 44(2): 186 - 190.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. A. Graham and J. W. E. Rush
Exercise training improves aortic endothelium-dependent vasorelaxation and determinants of nitric oxide bioavailability in spontaneously hypertensive rats
J Appl Physiol, June 1, 2004; 96(6): 2088 - 2096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. K. Johnson, W. Durante, K. J. Peyton, and R. A. Johnson
Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1681 - H1687.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. M. Harrison-Bernard, I. H. Schulman, and L. Raij
Postovariectomy Hypertension Is Linked to Increased Renal AT1 Receptor and Salt Sensitivity
Hypertension, December 1, 2003; 42(6): 1157 - 1163.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij
In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II
Hypertension, November 1, 2003; 42(5): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.-K. Siegel, M. Planert, S. Rademacher, A. P. Mehr, P. Kossmehl, M. Wehland, M. Stoll, and R. Kreutz
Genetic Loci Contribute to the Progression of Vascular and Cardiac Hypertrophy in Salt-Sensitive Spontaneous Hypertension
Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1211 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Gschwend, H. Buikema, R. H. Henning, Y. M. Pinto, D. de Zeeuw, and W. H. van Gilst
Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failure
Eur J Heart Fail, March 1, 2003; 5(2): 147 - 154.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C.-H. Yen and Y.-T. Lau
Vascular Responses in Male and Female Hypertensive Rats With Hyperhomocysteinemia
Hypertension, September 1, 2002; 40(3): 322 - 328.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. R. Standley, M. A. Stanley, and P. Senechal
Activation of mitogenic and antimitogenic pathways in cyclically stretched arterial smooth muscle
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1165 - E1171.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Galderisi, G. Vitale, G. Lupoli, M. Barbieri, G. Varricchio, C. Carella, O. de Divitiis, and G. Paolisso
Inverse Association Between Free Insulin-Like Growth Factor-1 and Isovolumic Relaxation in Arterial Systemic Hypertension
Hypertension, October 1, 2001; 38(4): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Grieve, P. A. MacCarthy, N. P. Gall, A. C. Cave, and A. M. Shah
Divergent Biological Actions of Coronary Endothelial Nitric Oxide During Progression of Cardiac Hypertrophy
Hypertension, August 1, 2001; 38(2): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Raij
Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction
Hypertension, February 1, 2001; 37(2): 767 - 773.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. V. d'Uscio, T. Quaschning, J. C. Burnett Jr, and T. F. Luscher
Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition
Hypertension, January 1, 2001; 37(1): 28 - 33.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. K. Roberts, N. D. Vaziri, X. Q. Wang, and R. J. Barnard
Enhanced NO Inactivation and Hypertension Induced by a High-Fat, Refined-Carbohydrate Diet
Hypertension, September 1, 2000; 36(3): 423 - 429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Ishizaka, T. Aizawa, I. Mori, J.-I. Taguchi, Y. Yazaki, R. Nagai, and M. Ohno
Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H672 - H678.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Ren, L. Jefferson, J. R. Sowers, and R. A. Brown
Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats
Hypertension, December 1, 1999; 34(6): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Ni, F. Oveisi, and N. D. Vaziri
Nitric Oxide Synthase Isotype Expression in Salt-Sensitive and Salt-Resistant Dahl Rats
Hypertension, October 1, 1999; 34(4): 552 - 557.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Bartunek, S. Dempsey, E. O. Weinberg, N. Ito, M. Tajima, S. Rohrbach, and B. H. Lorell
Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve
J. Am. Coll. Cardiol., August 1, 1998; 32(2): 528 - 535.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Raij
Nitric Oxide in Hypertension: Relationship With Renal Injury and Left Ventricular Hypertrophy
Hypertension, January 1, 1998; 31(1): 189 - 193.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Hayakawa and L. Raij
Nitric Oxide Synthase Activity and Renal Injury in Genetic Hypertension
Hypertension, January 1, 1998; 31(1): 266 - 270.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Barton, L. V. d'Uscio, S. Shaw, P. Meyer, P. Moreau, and T. F. Luscher
ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension
Hypertension, January 1, 1998; 31(1): 499 - 504.
[Abstract] [Full Text] [PDF]